Acorda Therapeutics Inc (NASDAQ:ACOR)

33.43
Delayed Data
As of Jun 29
 -0.50 / -1.47%
Today’s Change
28.26
Today|||52-Week Range
45.45
-18.20%
Year-to-Date

Today’s Trading

Previous close33.93
Today’s open33.72
Day’s range-- - --
Volume818,804
Average volume (3 months)617,558
Market cap$1.5B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-207.41%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio102.3
Price/Sales4.33
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.70-8.58%
INSMInsmed Inc-1.14-4.64%
RGENRepligen Corp-0.81-1.92%
MACKMerrimack Pharmaceut...-0.64-5.10%
Data as of 06/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers